Abstract guidelines

CALL FOR ABSTRACTS

The WOC2022® welcomes abstracts in all subspecialties of Ophthalmology. Please review the abstract submission instructions as outlined below prior to submitting your abstract. Any questions? Contact our team at [email protected].

Key Dates

  • 12 January 2022: Abstract submission open
  • 2 May 2022: Abstract submission deadline [CLOSED]
  • 31 May 2022: Abstract notification of acceptance
  • 20 June 2022: Presenter registration deadline (Early bird deadline)

Submission Categories

Abstracts for the Submitted Program will be accepted into the following 20 subspecialties of Ophthalmology:

  • Cataract and Lens Surgery
  • Contact Lens and Refraction
  • Cornea, External Eye Diseases, and Eye Banking
  • Glaucoma
  • International Eye Care and Eye Care Delivery
  • Medical Retina
  • Neuro-ophthalmology
  • Ocular Imaging
  • Ophthalmic Education/Young Ophthalmologists
  • Ophthalmic Epidemiology
  • Ocular Oncology
  • Ophthalmic Trauma
  • Ophthalmic Pathology and Microbiology
  • Orbital, Oculoplastic, and Lacrimal Diseases
  • Pediatric Ophthalmology and Strabismus
  • Refractive Surgery
  • Surgical Retina
  • Uveitis
  • Vision Rehabilitation
  • Vision Sciences

Abstract Rules

Maximum character limit: 2500 characters

Language of submission: English. Please take time to check your abstract for any spelling errors before final submission.

Abstract titles are limited to 130 characters or less. The title should be dynamic and conclusive, rather than descriptive, and should be entered in title case format (you should capitalize only the first letter of each word, unless it is a preposition or article).

Abstracts should be structured as follows: Objective, Methods, Results and Conclusion.

Supplemental figures/tables/references are not permitted.

Abstracts being submitted must be original research. Any abstract violating copyright laws and/or including plagiarized content will be rejected.

Submitters may not split one study into several papers.

Authors Rules

  • Individuals may only be the main presenter for a maximum of two submitted abstracts, and each individual may only submit a maximum of two abstracts.
  • Individuals may co-author multiple abstracts.
  • Each author should be added separately to the submission to ensure proper listing.

Presentation Formats

At the time of submission, you will be asked to select your preferred format of presentation. However, not all requests can be accommodated, and the final presentation format of your abstract will be determined by the Abstract Committee.

  • Free Paper Presentation

Free paper sessions are organized around a central subspecialty and are made up of multiple presenters delivering their abstract as a 7-minute oral presentation, followed by 3 minutes for questions and answer/discussion with the audience.

  • Case Presentation

Selected cases will be included in grand rounds sessions organized around a central subspecialty. The session will include multiple 5-minute case presentations, each followed by a 10-minute discussion by a panel of international experts.

  • E-Poster Presentation

A select number of accepted E-posters will be organized into E-poster sessions, and the presenting author will have an opportunity to record a short oral presentation. The E-poster presentation is limited to a 5-minute recorded presentation and maximum seven slides: a title slide, financial disclosure slide and then one slide for each of these areas: objective/purpose, materials/patients, methods, results and conclusion.

  • E-Poster

Electronic display of the latest research results in the field of study. E-Posters should be displayed on one page only, showing the objective, methods, results and conclusions at a glance, in a condensed yet attractive format for quick learning. The E-Poster will be grouped per theme and available to explore at all times on the virtual congress platform.

  • Videos

Short videos of one to five minutes maximum in length. Videos can include presentations of a new examination, investigation, technique or presentation of an interesting case and how it was managed. The top-scored videos will have a chance to be featured in a “Best of Videos” session.

Presenter Agreement

All presenting authors must agree to the following conditions when submitting an abstract:

  • Any work with human or animal subjects reported in the abstract complies with the guiding principles for experimental procedures found in the Declaration of Helsinki of the World Medical Association, and this research project has been duly cleared by my Institutional Review Board (IRB).
  • If the abstract is accepted, the ICO has permission to publish the abstract in printed and/or electronic formats.
  • Register for the meeting and pay the appropriate registration fee by the presenter registration deadline (20 June 2022).
  • By submitting an abstract to the ICO, and in consideration for the opportunity to be included in the WOC presentations, the author(s) of the abstract hereby provides to the ICO a non-exclusive, irrevocable, worldwide, royalty-free license to use the abstract in the ICO’s electronic mediums and printed materials.
  • The author(s) grants the permission to reproduce his/her image (including photos) to create documentation to be published on the internet (including streaming) and to make the audio/video recording (synchro recording system), and photographs of the presentation to produce educational materials. The presentation will be reproduced in full compliance with its contents both in terms of scientific results and information, associated with the image and the data of the undersigned.

Acceptance Notification

All abstracts received by the indicated deadline will be evaluated by the Submitted Program Committee. Acceptance will be notified to the submitting author by 31 May 2022.

The International Council of Ophthalmology looks forward to receiving your abstract for inclusion in the scientific program of the 38th World Ophthalmology Congress!
For any questions, please contact the WOC2022® Organizing Secretariat at [email protected]